Nociceptin/Orphanin FQ (N/OFQ)-evoked bradycardia, hypotension, and diuresis are absent in N/OFQ peptide (NOP) receptor knockout mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 326, Issue 3, 2008, Pages 897-904

  Burmeister, Melissa A ^a   Ansonoff, Michael A ^c   Pintar, John E ^c   Kapusta, Daniel R ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOCICEPTIN; NOCICEPTIN RECEPTOR; OPIATE PEPTIDE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BRADYCARDIA; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DEPRESSOR RESPONSE; DIURESIS; DOSE RESPONSE; HEART RATE; HYPOTENSION; KIDNEY FUNCTION; KNOCKOUT MOUSE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SODIUM URINE LEVEL; TRANSGENIC MOUSE; URINE VOLUME; WILD TYPE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; GENETICS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; BRADYCARDIA; DIURESIS; HYPOTENSION; INJECTIONS, INTRAVENTRICULAR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; OPIOID PEPTIDES; RECEPTORS, OPIOID;

EID: 52649113268     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.135905     Document Type: Article

References (36)

1. Bertorelli R, Bastia E, Citterio F, Corradini L, Forlani A, and Ongini E (2002) Lack of the nociceptin receptor does not affect acute or chronic nociception in mice. Peptides 23:1589-1596.
2. Burmeister MA and Kapusta DR (2007) Centrally administered nociceptin/orphanin FQ (N/OFQ) evokes bradycardia, hypotension and diuresis in mice via activation of central N/OFQ peptide (NOP) receptors. J Pharmacol Exp Ther 322:324-331.
3. Calo G, Guerrini R, Rizzi A, Salvadori S, Burmeister M, Kapusta DR, Lambert DG, and Regoli D (2005) UFP-101, a peptide antagonist selective for the nociceptin/ orphanin FQ receptor. CNS Drug Rev 11:97-112.
4. Carr DB and Verrier RL (1991) Opioids in pain and cardiovascular responses: overview of common features. J Cardiovasc Electrophysiol 2:s34-s42.
5. Chen Y, Chang M, Wang ZZ, Chen LX, Yang Q, Qi YM, and Wang R (2002) [NPHE1]nociceptin(1-13)-NH2 antagonizes nociceptin-induced hypotension, bradycardia, and hindquarters vasodilation in the anesthetized rat. Can J Physiol Pharmacol 80:31-35.
6. Clarke S, Chen Z, Hsu MS, Pintar J, Hill R, and Kitchen I (2001) Quantitative autoradiographic mapping of the ORL1, mu-, delta- and kappa-receptors in the brains of knockout mice lacking the ORL1 receptor gene. Brain Res 906:13-24.
7. Faulx MD, Ernsberger P, Vatner D, Hoffman RD, Lewis W, Strachan R, and Hoit BD (2005) Strain-dependent -adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice. Am J Physiol Heart Circ Physiol 289:H30-H36.
8. Gavioli EC, Marzola G, Guerrini R, Bertorelli R, Zucchini S, De Lima TC, Rae GA, Salvadori S, Regoli D, and Calo G (2003) Blockade of nociceptin/orphanin FQ-NOP receptor signaling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test. Eur J Neurosci 17:1987-1990.
9. Gavioli EC, Rizzi A, Marzola G, Zucchini S, Regoli D, and Caló G (2007) Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice. Peptides 28:1229-1239.
10. Gavioli EC, Vaughan CW, Marzola G, Guerrini R, Mitchell VA, Zucchini S, De Lima TC, Rae GA, Salvadori S, Regoli D, et al. (2004) Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice. Naunyn Schmiedebergs Arch Pharmacol 369:547-553.
11. Grottick AJ, Bagnol D, Phillips S, McDonald J, Behan DP, Chalmers DT, and Hakak Y (2005) Neurotransmission- and cellular stress-related gene expression associated with prepulse inhibition in mice. Brain Res Mol Brain Res 139:153-162.
12. Kapusta DR and Obih JC (1995) Role of endogenous central opioid mechanisms in maintenance of body sodium balance. Am J Physiol Regul Integr Comp Physiol 268:R723-R730.
13. Kapusta DR and Kenigs VA (1999) Cardiovascular and renal responses produced by central orphanin FQ/nociceptin occur independent of renal nerves. Am J Physiol Regul Integr Comp Physiol 277:R987-R995.
14. Kapusta DR, Sezen SF, Chang JK, Lippton H, and Kenigs VA (1997) Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Life Sci 60:PL15-PL21.
15. Koepke JP and DiBona GF (1986) Central adrenergic receptor control of renal function in conscious hypertensive rats. Hypertension 8:133-141.
16. Krowicki ZK and Kapusta DR (2006) Tonic nociceptinergic inputs to neurons in the hypothalamic paraventricular nucleus contribute to sympathetic vasomotor tone and water and electrolyte homeostasis in conscious rats. J Pharmacol Exp Ther 317:446-453.
17. Lachowicz JE, Shen Y, Monsma FJ Jr, and Sibley DR (1995) Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J Neurochem 64:34-40.
18. Madeddu P, Salis MB, Milia AF, Emanueli C, Guerrini R, Regoli D, and Calò G (1999) Cardiovascular effects of nociceptin in unanesthetized mice. Hypertension 33:914-919.
19. Mamiya T, Noda Y, Ren X, Nagai T, Takeshima H, Ukai M, and Nabeshima T (2001) Morphine tolerance and dependence in the nociceptin receptor knockout mice. J Neural Transm 108:1349-1361.
20. Manabe T, Noda Y, Mamiya T, Katagiri H, Houtani T, Nishi M, Noda T, Takahashi T, Sugimoto T, Nabeshima T, et al. (1998) Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 394:577-581.
21. Meunier JC, Molereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour J, Guillemot J, Ferrara P, Monsarrat B, et al. (1995) Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377:532-535.
22. Mollereau C, Mouledous L, Lapalu S, Cambois G, Moisand C, Butour JL, and Meunier JC (1999) Distinct mechanisms for activation of the opioid receptor-like 1 and kappa-opioid receptors by nociceptin and dynorphin A. Mol Pharmacol 55:324-331.
23. Nishi M, Houtani T, Noda Y, Mamiya T, Sato K, Doi T, Kuno J, Takeshima H, Nukada T, Nabeshima T, et al. (1997) Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphaninFQ receptor. EMBO J 16:1858-1864.
24. Noda Y, Mamiya T, and Nabeshima T (1999) Behavioral pharmacological characterization of mice lacking the nociceptin receptor. Nihon Shinkei Seishin Yakurigaku Zasshi 19:73-78.
25. Okuda-Ashitaka E, Minami T, Matsumura S, Takeshima H, Reinscheid RK, Civelli O, and Ito S (2006) The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E2-induced allodynia, tactile pain associated with nerve injury. Eur J Neurosci 23:995-1004.
26. Pan YX, Xu J, Wan BL, Zuckerman A, and Pasternak GW (1998) Identification and differential regional expression of KOR-3/ORL-1 gene splice variants in mouse brain. FEBS Lett 435:65-68.
27. Patel KP and Zeigler DW (1993) Renal nerves are involved in the natriuresis and diuresis produced by central administration of clonidine in the rat. Proc Soc Exp Biol Med 202:81-87.
28. Paxinos G and Franklin KBJ (2003) The Mouse Brain in Stereotaxic Coordinates, 2nd ed, Academic Press, New York.
29. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ Jr, and Civelli O (1995) Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science 270:792-794.
30. Rizzi D, Calo G, Guerrini R, and Kapusta DR (2004) Renal effects produced by central activation of the N/OFQ-NOP receptor system: an in vivo study in mice. FASEB J, in press.
31. Shirasaka T, Kunitake T, Kato K, Takasaki M, and Kannan H (1999) Nociceptin modulates renal sympathetic nerve activity through a central action in conscious rats. Am J Physiol Regul Integr Comp Physiol 277:R1025-R1032.
32. Stiedl O, Radulovic J, Lohmann R, Birkenfeld K, Palve M, Kammermeier J, Sananbenesi F, and Spiess J (1999) Strain and substrain differences in context- and tone-dependent fear conditioning of inbred mice. Behav Brain Res 104:1-12.
33. Szabo B (2002) Imidazoline antihypertensive drugs: a critical review on their mechanism of action. Pharmacol Ther 93:1-35.
34. Ueda H (2004) Anti-opioid systems in morphine tolerance and addiction-locus-specific involvement of nociceptin and the NMDA receptor. Novartis Found Symp 261:155-162.
35. Vanderah TW, Raffa RB, Lashbrook J, Burritt A, Hruby V, and Porreca F (1998) Orphanin-FQ/nociceptin: lack of antinociceptive, hyperalgesic or allodynic effects in acute thermal or mechanical tests following intracerebroventricular or intrathecal administration to mice or rats. Eur J Pain 2:267-280.
36. Zhang X, Zhu CB, Shu H, Liu J, Wang YY, Wang Y, and Liu HY (1999) Effect of OFQ injection into intracerebroventricular and preoptic area on blood pressure and heart rate in rats. Sheng Li Xue Bao 51:580-584.